CRONOS GROUP INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
CRONOS GROUP INC. (CRON) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-02-26
- CRONOS GROUP INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was 2.96 CAD/shares.
- CRONOS GROUP INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2019-03-31 was 24.75 CAD/shares.
- CRONOS GROUP INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was 0.00 CAD/shares, a 100.00% decline from fiscal 2023.
- CRONOS GROUP INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was 2.96 CAD/shares, a 29.52% decline from fiscal 2022.
- CRONOS GROUP INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was 4.20 CAD/shares, a 54.30% decline from fiscal 2021.
- CRONOS GROUP INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was 9.19 CAD/shares, a 32.04% increase from fiscal 2020.
CAD/shares
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2024-12-31 | 0.00 CAD/shares 10-K · filed 2025-02-27 | |||
| 2023-12-31 | 2.96 CAD/shares 10-K · filed 2025-02-27 | |||
| 2023-09-30 | 2.96 CAD/shares 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | 2.96 CAD/shares 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | 2.96 CAD/shares 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | 4.20 CAD/shares 10-K · filed 2024-02-29 | |||
| 2021-12-31 | 9.19 CAD/shares 10-K · filed 2023-02-28 | |||
| 2021-09-30 | 9.19 CAD/shares 10-Q · filed 2022-11-07 | |||
| 2020-12-31 | 6.96 CAD/shares 10-K · filed 2022-03-01 | |||
| 2020-09-30 | 6.96 CAD/shares 10-Q · filed 2022-02-18 | |||
| 2019-12-31 | 20.08 CAD/shares 10-K · filed 2021-02-26 | |||
| 2019-09-30 | 20.08 CAD/shares 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | 20.81 CAD/shares 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | 24.75 CAD/shares 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | 8.23 CAD/shares 10-K/A · filed 2020-03-30 | |||
| 2017-12-31 | 2.82 CAD/shares 10-K/A · filed 2020-03-30 |
USD/shares
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |